Ophthalmoparesis as an unusual manifestation of anti-3‑hydroxy-3-methyl-glutaryl-coenzyme A reductase antibody-associated myopathies

Keyphrases

• Ophthalmoparesis 100%
• Methyl 100%
• Creatine Kinase 100%
• Myopathy 100%
• Reductase 100%
• Coenzyme A 100%
• Antibody-associated 100%
• Unusual Manifestation 100%
• Ptosis 66%
• Diplopia 66%
• Limb Weakness 66%
• Anti-HMGCR Antibody 66%
• Magnetic Resonance Imaging 33%
• Myofiber 33%
• Young Female 33%
• Weakly Positive 33%
• Dyspnea 33%
• Young Males 33%
• Phenotypic Spectrum 33%
• Electromyography 33%
• Dysphagia 33%
• Dysarthria 33%
• Muscle Biopsy 33%
• Fibrillation Potentials 33%
• Proximal Weakness 33%
• Immunomodulatory Therapy 33%
• Myopathic 33%
• Repetitive Nerve Stimulation 33%
• Extraocular muscles 33%
• Abnormal Enhancement 33%
• Normal Thyroid 33%
• Limb-girdle muscle Weakness 33%
• Elevated Creatine Kinase 33%
• HMGCR Antibody 33%
• Anti-PM-Scl Antibody 33%

Medicine and Dentistry

• Ophthalmoparesis 100%
• Oxidoreductase 100%
• Creatine Kinase 100%
• Myopathy 100%
• Coenzyme A 100%
• Weakness 75%
• Ptosis 50%
• Diplopia 50%
• Limb Weakness 50%
• Magnetic Resonance Imaging 25%
• Thyroid Gland 25%
• Limb 25%
• Plummer-Vinson Syndrome 25%
• Extraocular Muscle 25%
• Dyspnea 25%
• Electromyography 25%
• Dysarthria 25%
• Muscle Biopsy 25%
• Fibrillation 25%
• Repetitive Nerve Stimulation 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Oxidoreductase 100%
• Creatine Kinase 100%
• Myopathy 100%
• Ophthalmoplegia 100%
• Coenzyme A 100%
• Weakness 75%
• Diplopia 50%
• Limb Weakness 50%
• Dyspnea 25%
• Dysphagia 25%
• Dysarthria 25%